Market Size and Growth Drivers
The anti aging usa market was valued at approximately $62 billion in 2023 and is projected to grow at a compound annual growth rate of over 7 percent through 2030, driven by rising demand for cosmeceuticals, nutraceuticals, and aesthetic procedures. The sector includes skincare, supplements, injectables, and longevity services, with the United States accounting for the largest share of global revenue. According to industry analysis, the segment is expanding as the population aged 65 and older exceeds 55 million and consumer willingness to pay for wellness and appearance products increases Forbes.
Key growth drivers include advances in peptide and stem cell research, increased direct-to-consumer e-commerce channels, and broader insurance coverage for certain preventive therapies. The U.S. Food and Drug Administration regulates drugs, devices, and cosmetics separately, creating distinct pathways for products that claim to treat aging versus those that only beautify the skin. Companies often pursue multiple regulatory tracks, with some products classified as cosmetics and others as drugs requiring new drug applications FDA.
Leading Companies and Investment Activity
Public and private firms shaping the anti aging usa landscape include Estée Lauder, L'Oréal, and Amgen, alongside venture-backed longevity startups such as Altos Labs and Calico, which have raised billions in private capital to study cellular reprogramming and age-related disease. These companies operate across research, consumer brands, and clinical services, with strategic partnerships and acquisitions accelerating product pipelines.
Venture funding in longevity and anti aging therapeutics reached record levels in recent years, with major investors backing platforms focused on senolytics, epigenetic clocks, and AI-driven drug discovery. Public companies increasingly report anti aging related revenue streams in their financial filings, and the SEC requires clear disclosure of risks, clinical data, and regulatory status for products making anti aging claims SEC EDGAR.
Regulatory Framework and Consumer Guidance
FDA Oversight of Anti Aging Products
The FDA categorizes anti aging products as cosmetics, drugs, or devices depending on intended use, with drugs requiring premarket approval and cosmetics subject to labeling and safety standards but not premarket review. Products claiming to treat wrinkles, age spots, or loss of elasticity may be regulated as drugs if they affect the structure or function of the body, while purely beautifying claims fall under cosmetic rules.
Consumers can verify FDA approval status using the agency's online databases, and the Federal Trade Commission monitors advertising claims to prevent deceptive marketing in the anti aging space. The FTC requires substantiation for anti aging claims and enforces actions against companies that make unsupported promises about reversing aging or extending lifespan FTC.